Join today and have your say! It’s FREE!

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Last one standing: The most undervalued lithium stock?

Why this company could be the next big lithium buyout (Source: Lithium South Development Corp.) By Carlise Kane of The Equedia Letter Records are meant to be broken – but not this badly. After a record-breaking 2022, THIS industry is on...

Grenke, JinkoSolar, Velocity Minerals - continue buying gold or are there alternatives?

Nowhere in the world, was more gold bought in the first six months of 2020 than in Germany. Coins and bars in the amount of about 83 tons went into the hands of the citizens. According to the World Gold Council, this represents an increase of 120% compared to the same period l...

Trillion Energy (CSE:TCF) announces substantial 2022 year-end reserves report

Trillion Energy (TCF) has shared its third-party December 31, 2022 year-end reserves report Net present value of proved and probable (P2) natural gas reserves (NPV10%) increased to US$432 million net to Trillion, up from US$82 million (2021), a 426-per-cent ...

Site Visit Shows Mining Company Now in Development Phase

Project highlights gleaned during the trip are recounted in a BMO Capital Markets report. In a May 21 research note, BMO Capital Markets analyst Andrew Mikitchook reported that during a recent multisite tour, Ivanhoe Mines Ltd.'s (IVN:TSX; IVPAF:OTCQX) "wo...

Inovio Pharma Awarded $9M Development Grant for Coronavirus Vaccine

Inovio Pharmaceuticals' shares rose 30%, setting a new 52-week high price, after the firm reported it received a grant of up to $9 million to develop a vaccine against the coronavirus. Among ongoing worldwide concerns, biotechnology firm Inovio Pharmaceuticals Inc. (IN...

Cortexyme Secures $125M Private Placement Capital to Advance Clinical Development

Shares of Cortexyme Inc. traded 20% higher after the company reported that it secured an additional $125M in capital from a private placement. The firm intends to use the proceeds to fund current Alzheimer's clinical trials and ongoing operations. Clinical s...

Leading Edge Materials: Positioning for the EU’s critical minerals push

By David Yeoman, Crux Investor Leading Edge Materials has a portfolio of critical raw materials projects in the EU, including the Norra Kärr heavy rare earths project in Sweden, the Woxna graphite mine in Sweden, and an exploration program in Romania. ...

Avid Bioservices' Shares Rise on Q2/20 Earnings and Confirmed Outlook

Shares of Avid Bioservices traded higher today, reaching a new 52-week high, after the firm reported Q2/20 earnings and reaffirmed its revenue guidance for Full-Year 2020. After the U.S. financial markets closed yesterday, biologics contract development and manufactur...

Memphasys, Moderna, Paion - Investments in solutions with potential

Biotech companies around the world employ scientists and physicians to study the causes of diseases. The research and development of medical products and solutions usually involves a large number of tests and takes a correspondingly long time. The longer and more extensive thi...

Eton Pharma Shares Climb 20% After Firm Secures US Rights for Pediatric Kidney Disease Drug

Shares of Eton Pharmaceuticals traded higher after the company reported that it has acquired U.S. marketing rights to pediatric orphan drug Alkindi® Sprinkle from Diurnal Group Plc. Eton Pharmaceuticals Inc. (ETON:NASDAQ) , which is focused on devel...
1 2 3 4 5 6 7 8 9 10 ...